C World Wide Group Holding A Gilead Sciences, Inc. Transaction History

C World Wide Group Holding A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $12.2 Million - $13.6 Million	-196,598 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $693,645 - $777,064	-11,093 Reduced 5.34%	196,598 $12.8 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $327,703 - $427,627	-5,413 Reduced 2.54%	207,691 $13 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $2.34 Million - $2.59 Million	-32,879 Reduced 13.37%	213,104 $16.5 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $2.13 Million - $2.49 Million	-32,887 Reduced 11.79%	245,983 $17.4 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $5.32 Million - $6.49 Million	-73,038 Reduced 20.75%	278,870 $21 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $281 Million - $330 Million	-3,955,127 Reduced 91.83%	351,908 $25.2 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $311 Million - $368 Million	4,307,035	4,307,035 $349 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.